PAXMEDICA INC (PXMD) Fundamental Analysis & Valuation

NASDAQ:PXMD • US70424C2035

Current stock price

0.6883 USD
-0.06 (-7.61%)
At close:
0.37 USD
-0.32 (-46.24%)
After Hours:

This PXMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PXMD Profitability Analysis

1.1 Basic Checks

  • In the past year PXMD has reported negative net income.
  • In the past year PXMD has reported a negative cash flow from operations.
  • In the past 5 years PXMD always reported negative net income.
  • In the past 5 years PXMD always reported negative operating cash flow.
PXMD Yearly Net Income VS EBIT VS OCF VS FCFPXMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

  • PXMD's Return On Assets of -321.98% is on the low side compared to the rest of the industry. PXMD is outperformed by 94.39% of its industry peers.
  • Looking at the Return On Equity, with a value of -540.30%, PXMD is doing worse than 83.16% of the companies in the same industry.
Industry RankSector Rank
ROA -321.98%
ROE -540.3%
ROIC N/A
ROA(3y)-856.18%
ROA(5y)-1309.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PXMD Yearly ROA, ROE, ROICPXMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

  • PXMD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PXMD Yearly Profit, Operating, Gross MarginsPXMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PXMD Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for PXMD has been increased compared to 1 year ago.
  • There is no outstanding debt for PXMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PXMD Yearly Shares OutstandingPXMD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M
PXMD Yearly Total Debt VS Total AssetsPXMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

  • PXMD has an Altman-Z score of -20.05. This is a bad value and indicates that PXMD is not financially healthy and even has some risk of bankruptcy.
  • PXMD has a Altman-Z score of -20.05. This is amonst the worse of the industry: PXMD underperforms 86.22% of its industry peers.
  • There is no outstanding debt for PXMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -20.05
ROIC/WACCN/A
WACCN/A
PXMD Yearly LT Debt VS Equity VS FCFPXMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 -5M -10M

2.3 Liquidity

  • PXMD has a Current Ratio of 3.16. This indicates that PXMD is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 3.16, PXMD perfoms like the industry average, outperforming 51.02% of the companies in the same industry.
  • PXMD has a Quick Ratio of 3.16. This indicates that PXMD is financially healthy and has no problem in meeting its short term obligations.
  • PXMD has a Quick ratio (3.16) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 3.16
PXMD Yearly Current Assets VS Current LiabilitesPXMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. PXMD Growth Analysis

3.1 Past

  • PXMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.95%, which is quite impressive.
EPS 1Y (TTM)23.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y88.34%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PXMD Yearly EPS VS EstimatesPXMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

0

4. PXMD Valuation Analysis

4.1 Price/Earnings Ratio

  • PXMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PXMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PXMD Price Earnings VS Forward Price EarningsPXMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PXMD Per share dataPXMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PXMD Dividend Analysis

5.1 Amount

  • No dividends for PXMD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PXMD Fundamentals: All Metrics, Ratios and Statistics

PAXMEDICA INC

NASDAQ:PXMD (5/1/2024, 8:18:16 PM)

After market: 0.37 -0.32 (-46.24%)

0.6883

-0.06 (-7.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-11
Earnings (Next)05-13
Inst Owners0%
Inst Owner Change0%
Ins Owners100.3%
Ins Owner Change0%
Market Cap5.10M
Revenue(TTM)N/A
Net Income(TTM)-18.29M
AnalystsN/A
Price Target3.06 (344.57%)
Short Float %0.01%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-15.85
EYN/A
EPS(NY)-1.11
Fwd EYN/A
FCF(TTM)-1.45
FCFYN/A
OCF(TTM)-1.45
OCFYN/A
SpS0
BVpS0.46
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -321.98%
ROE -540.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-856.18%
ROA(5y)-1309.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 3.16
Altman-Z -20.05
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.11%
EPS Next Y88.34%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.41%
OCF growth 3YN/A
OCF growth 5YN/A

PAXMEDICA INC / PXMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PAXMEDICA INC (PXMD) stock?

ChartMill assigns a fundamental rating of 2 / 10 to PXMD.


Can you provide the valuation status for PAXMEDICA INC?

ChartMill assigns a valuation rating of 0 / 10 to PAXMEDICA INC (PXMD). This can be considered as Overvalued.


How profitable is PAXMEDICA INC (PXMD) stock?

PAXMEDICA INC (PXMD) has a profitability rating of 0 / 10.


Can you provide the financial health for PXMD stock?

The financial health rating of PAXMEDICA INC (PXMD) is 6 / 10.